This page shows Office Pptys Income Tr (OPITQ) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Positive operating cash flow is being squeezed by a rising financing burden, with liquidity preserved through balance-sheet actions.
Across FY2020-FY2024, debt-to-equity climbed from 1.4x to 2.2x while long-term debt stayed in roughly the same band, so the leverage worsening came mainly from equity erosion. That matters because interest expense reached$163.7M in FY2024 as operating cash flow fell to$67.2M , meaning financing claims now outweigh the cash the business is currently producing.
FY2024's net loss of
Cash jumped to
Financial Health Signals
Based on FY2024 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Office Pptys Income Tr's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Office Pptys Income Tr has a moderate D/E ratio of 2.20. This balance of debt and equity financing earns a leverage score of 57/100.
Office Pptys Income Tr generates a -11.8% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -5.5% the prior year.
Office Pptys Income Tr passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Office Pptys Income Tr generates $-0.49 in operating cash flow ($67.2M OCF vs -$136.1M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Key Financial Metrics
Earnings & Revenue
Office Pptys Income Tr reported -$136.1M in net income in fiscal year 2024. This represents a decrease of 96.0% from the prior year.
Office Pptys Income Tr earned $-2.63 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 82.6% from the prior year.
Cash & Balance Sheet
Office Pptys Income Tr held $261.3M in cash against $2.5B in long-term debt as of fiscal year 2024.
Office Pptys Income Tr paid $0.04 per share in dividends in fiscal year 2024. This represents a decrease of 96.9% from the prior year.
Office Pptys Income Tr had 70M shares outstanding in fiscal year 2024. This represents an increase of 43.2% from the prior year.
Margins & Returns
Office Pptys Income Tr's ROE was -11.8% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 6.3 percentage points from the prior year.
Capital Allocation
Office Pptys Income Tr spent $192K on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 34.7% from the prior year.
OPITQ Income Statement
| Metric | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $114.5M+0.8% | $113.6M | N/A | N/A | $123.7M-11.3% | $139.4M | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $4.8M-4.8% | $5.1M | N/A | $4.9M-6.9% | $5.3M-6.3% | $5.6M | N/A | $5.7M |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $52.5M-1.6% | $53.4M | N/A | $42.6M+11.0% | $38.3M+8.1% | $35.5M | N/A | $28.8M |
| Income Tax | $94K-31.4% | $137K | N/A | $230K+315.0% | -$107K-291.1% | $56K | N/A | $95K |
| Net Income | -$41.2M+10.2% | -$45.9M | N/A | -$58.4M-176.7% | $76.2M+1569.3% | -$5.2M | N/A | -$19.6M |
| EPS (Diluted) | $-0.58+12.1% | $-0.66 | N/A | $-1.14-173.1% | $1.56+1518.2% | $-0.11 | N/A | $-0.41 |
OPITQ Balance Sheet
| Metric | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.6B-0.2% | $3.6B-6.6% | $3.8B+2.6% | $3.7B-1.9% | $3.8B-4.0% | $4.0B-0.8% | $4.0B-1.4% | $4.0B |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $78.2M+22.6% | $63.7M-75.6% | $261.3M+1068.5% | $22.4M+65.7% | $13.5M-42.6% | $23.5M+90.9% | $12.3M-49.4% | $24.4M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | $155.7M+6.2% | $146.6M+4.3% | $140.5M+2.2% | $137.5M+3.2% | $133.3M+7.4% | $124.0M |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $2.5B+1.3% | $2.5B-7.7% | $2.7B+9.1% | $2.4B-0.9% | $2.5B-8.8% | $2.7B-1.0% | $2.7B-0.2% | $2.7B |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | $2.5B | N/A | N/A | N/A | $2.6B | N/A |
| Total Equity | $1.1B-3.7% | $1.1B-4.0% | $1.2B-9.8% | $1.3B-3.8% | $1.3B+6.3% | $1.3B-0.4% | $1.3B-3.8% | $1.3B |
| Retained Earnings | -$123.0M-50.3% | -$81.8M-127.6% | -$35.9M-131.9% | $112.7M-34.1% | $171.2M+80.2% | $95.0M-5.2% | $100.2M-27.1% | $137.3M |
OPITQ Cash Flow Statement
| Metric | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $32.4M+213.3% | -$28.6M-211.1% | $25.7M+250.8% | -$17.1M-153.5% | $31.9M+19.7% | $26.6M-18.3% | $32.6M+55.9% | $20.9M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$10.5M-170.0% | $15.0M-81.2% | $79.9M+894.4% | $8.0M+147.5% | -$16.9M-287.9% | -$4.4M+88.5% | -$37.9M-40.4% | -$27.0M |
| Financing Cash Flow | -$6.6M+96.4% | -$185.0M-238.7% | $133.3M+1122.1% | $10.9M+144.2% | -$24.7M-405.7% | -$4.9M+36.1% | -$7.6M-138.4% | $19.9M |
| Dividends Paid | $709K+1.6% | $698K+25.5% | $556K+10.8% | $502K+2.9% | $488K+0.2% | $487K-96.0% | $12.2M+0.3% | $12.1M |
| Share Buybacks | $5K | $0-100.0% | $1K-99.4% | $170K+1033.3% | $15K+150.0% | $6K+100.0% | $3K-98.7% | $234K |
OPITQ Financial Ratios
| Metric | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | -36.0%+4.4pp | -40.4% | N/A | N/A | 61.6%+65.3pp | -3.7% | N/A | N/A |
| Return on Equity | -3.9%+0.3pp | -4.1% | N/A | -4.6%-10.3pp | 5.7%+6.1pp | -0.4% | N/A | -1.5% |
| Return on Assets | -1.2%+0.1pp | -1.3% | N/A | -1.6%-3.6pp | 2.0%+2.1pp | -0.1% | N/A | -0.5% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 2.34+0.1 | 2.23+0.0 | 2.20+0.3 | 1.91+0.1 | 1.86-0.3 | 2.17+0.1 | 2.05-0.1 | 2.10 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Frequently Asked Questions
Is Office Pptys Income Tr profitable?
No, Office Pptys Income Tr (OPITQ) reported a net income of -$136.1M in fiscal year 2024.
How much debt does Office Pptys Income Tr have?
As of fiscal year 2024, Office Pptys Income Tr (OPITQ) had $261.3M in cash and equivalents against $2.5B in long-term debt.
Does Office Pptys Income Tr pay dividends?
Yes, Office Pptys Income Tr (OPITQ) paid $0.04 per share in dividends during fiscal year 2024.
What is Office Pptys Income Tr's return on equity (ROE)?
Office Pptys Income Tr (OPITQ) has a return on equity of -11.8% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Office Pptys Income Tr's operating cash flow?
Office Pptys Income Tr (OPITQ) generated $67.2M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Office Pptys Income Tr's total assets?
Office Pptys Income Tr (OPITQ) had $3.8B in total assets as of fiscal year 2024, including both current and long-term assets.
What is Office Pptys Income Tr's debt-to-equity ratio?
Office Pptys Income Tr (OPITQ) had a debt-to-equity ratio of 2.20 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Office Pptys Income Tr's return on assets (ROA)?
Office Pptys Income Tr (OPITQ) had a return on assets of -3.6% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Office Pptys Income Tr's Piotroski F-Score?
Office Pptys Income Tr (OPITQ) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Office Pptys Income Tr's earnings high quality?
Office Pptys Income Tr (OPITQ) has an earnings quality ratio of -0.49x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Office Pptys Income Tr?
Office Pptys Income Tr (OPITQ) scores 10 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.